MSH6 and neoplasm: Uraki et al. studied the mismatch repair genes mutS homologs 6/2 (MSH6/2) and programmed cell death 1 ligand 1 (PD-L1), which are involved in tumor growth and tumor immunity, respectively, in a cohort of 73 NFPAs, 23 of them SCAs [56].